Oxford University to investigate AZD1775 for bowel cancer

19:00 EDT 3 Jul 2017 | Net Resources International

The UK's University of Oxford is set to investigate AstraZeneca’s experimental drug AZD1775 in a new clinical trial for treatment of patients with bowel cancer. 

Original Article: Oxford University to investigate AZD1775 for bowel cancer


More From BioPortfolio on "Oxford University to investigate AZD1775 for bowel cancer"

Quick Search


Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...